论文部分内容阅读
目的了解奥美拉唑联合莫沙必利对功能性消化不良的治疗效果。方法 100例功能性消化不良的患者,根据治疗药物的不同分为实验组和对照组,各50例。实验组患者采取奥美拉唑联合莫沙必利治疗,对照组患者采取奥美拉唑治疗。比较两组患者的治疗效果和不良反应发生情况。结果实验组治疗有效率为90%,高于对照组的78%,差异有统计学意义(P<0.05);实验组不良反应发生率为6%,对照组为8%(4例),两组比较差异无统计学意义(P>0.05)。结论功能性消化不良患者,采用奥美拉唑联合莫沙必利的治疗方式,要比单独应用奥美拉唑这一种药物时具有更加快速、更加有效且不良反应少的特点,值得临床推广应用。
Objective To understand the therapeutic effect of omeprazole combined with mosapride on functional dyspepsia. Methods 100 patients with functional dyspepsia were divided into experimental group and control group according to the different therapeutic drugs, 50 cases each. Patients in the experimental group were treated with omeprazole combined with mosapride, and patients in the control group were treated with omeprazole. The two groups of patients were compared with the treatment effect and adverse reactions. Results The effective rate of the experimental group was 90%, which was higher than that of the control group (78%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in the experimental group was 6% and in the control group was 8% (4 cases) There was no significant difference between the two groups (P> 0.05). Conclusions Patients with functional dyspepsia treated with omeprazole combined with mosapride have a faster, more effective and less adverse reactions than the omeprazole alone, which is worthy of clinical promotion application.